Invention Grant
- Patent Title: Crystalline form G of imatinib mesylate
- Patent Title (中): 甲磺酸伊马替尼的结晶形式G.
-
Application No.: US13183557Application Date: 2011-07-15
-
Publication No.: US08507515B2Publication Date: 2013-08-13
- Inventor: Michael Mutz
- Applicant: Michael Mutz
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Stephen Johnson
- Priority: GB0524061.9 20051125; GB0524062.7 20051125
- Main IPC: A61K31/505
- IPC: A61K31/505
Abstract:
Crystalline forms of imatinib mesylate (F, G, H, I and K) and their respective characterization are disclosed.
Public/Granted literature
- US20120015027A1 F, G, H, I and K Crystal Forms of Imatinib Mesylate Public/Granted day:2012-01-19
Information query
